Wockhardt USA - Our Other Websites

2008 Press Releases

July 28, 2008	Wockhardt’s Q2 Results 2008
April 28, 2008	Wockhardt’s Q1 Results 2008
February 13, 2008	Wockhardt enters the US market with generic version of Zithromax
January 9, 2008	Wockhardt to launch generic version of anti-depressant Zoloft in the US Market
January 1, 2008	Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US

October 27, 2007	Wockhardt acquires Morton Grove in the US
September 18, 2007	Wockhardt gets US FDA nod to enter the US$ 2.6 billion Norvasc market
July 09, 2007	Wockhardt to launch anti-epileptic injection, Fosphenytoin, in the US
June 20, 2007	Wockhardt to launch Cefprozil in the US
June 06, 2007	Wockhardt gets US FDA nod to enter the $680 million Lamisil market